Clare Morrow's peptide 'fountain of youth' claims fact-checked

What did @claremorrow_ifbbpro actually say?

The creator claims Jennifer Aniston's youthful appearance at 54 is linked to peptide use, specifically calling out GHK-Cu, ipamorelin/CJC-1295, and NAD. She says Aniston called peptides "the future of skincare" and personally endorses all three, adding she uses them herself at 51.

There are two separate conversations being conflated here. One is about topical peptides in skincare, which Aniston has mentioned in beauty press. The other is about injectable or oral bioactive peptides like ipamorelin, which operate through completely different mechanisms. The video treats these as one unified "celebrity routine" without distinguishing between a moisturizer ingredient and a growth hormone secretagogue. That's a significant problem, and viewers deserve to know the difference.

There's also no interview source cited. The quote attributed to Aniston, calling peptides "the future of skincare," is paraphrased loosely. We couldn't verify the original context or whether she was discussing topical products or systemic peptide therapy.

Does the science back this up?

On GHK-Cu specifically, the evidence is more credible than most influencers realize, though it's mostly preclinical. On ipamorelin/CJC-1295 and NAD, the picture is more complicated and the bar for human evidence is nowhere near what the enthusiasm suggests.

GHK-Cu (copper tripeptide-1) has genuine research behind it. Pickart and Margolina (2018, Biomolecules) reviewed decades of data showing GHK-Cu promotes collagen synthesis, stimulates wound repair, and has antioxidant properties in cell and animal models. Human clinical trials are limited but a 2009 study by Finkley et al. in the Journal of Cosmetic Dermatology showed improvement in fine lines with topical application. That's real, if modest, evidence.

Ipamorelin and CJC-1295 are growth hormone secretagogues. They stimulate GH release, and some small studies show increases in IGF-1 levels, but long-term safety data in healthy adults is thin. There are no peer-reviewed human trials specifically linking this combination to anti-aging outcomes in skin or appearance. The FDA has not approved either peptide for anti-aging use.

NAD precursors (like NMN or NR) have better human data than ipamorelin, with Yoshino et al. (2021, Science) showing metabolic improvements in postmenopausal women, but "anti-aging" effects in healthy adults remain speculative.

What did they get wrong (or right)?

Credit where it's due: the creator is right that peptides are amino acid chains, and right that GHK-Cu has legitimate skin research behind it. She's not inventing that from nothing.

Where this goes sideways is the celebrity attribution and the implied equivalency across very different compounds. Lumping a well-studied topical like GHK-Cu with systemic secretagogues like ipamorelin/CJC-1295, and presenting all three as part of Jennifer Aniston's verified routine, is misleading. There's no public evidence Aniston uses ipamorelin or CJC-1295. Aniston's publicly discussed skincare involves topical products and lifestyle factors.

The phrase "the best anti-aging peptides that her and other celebrities use" presents speculation as established fact. It isn't. Using a celebrity's name to drive supplement or peptide interest without confirmed association is a common influencer marketing pattern, and this video fits that pattern.

The creator also says "comment where I get my peptides if you want to know," which signals commercial intent. That doesn't automatically make the information wrong, but it does mean viewers should read the claims with that context in mind.

What should you actually know?

If you're interested in peptides for skin or longevity, the evidence hierarchy matters. Topical GHK-Cu has more human data than most peptides in this category. Injectable secretagogues like ipamorelin and CJC-1295 are a different category entirely, with different risk profiles and far less regulatory clarity.

In the US, ipamorelin and CJC-1295 are not FDA-approved drugs. They are available through compounding pharmacies, but the FDA has raised concerns about compounded peptides. In 2023 and 2024, the FDA moved several peptides to the "difficult to compound" category, which affects their legal availability.

NAD precursors are sold as supplements and have a cleaner legal status, but the anti-aging evidence in otherwise healthy adults is still early-stage. Anyone considering systemic peptide therapy should be working with a licensed clinician who can assess their individual hormone levels and health history, not following a routine sourced from a social media comment section.

The broader point is this: peptide science is real and advancing. That doesn't mean every claim made under the peptide umbrella is backed by equivalent evidence. Scrutinize the specific compound, the route of administration, and the quality of the studies before drawing conclusions.